Carl A. Ascoli, PhD

carl-ascoli_02.jpg

Carl A. Ascoli graduated from the University of Medicine and Dentistry of New Jersey in 1988.  Working with Dr. Gerd Maul at the Wistar Institute, he identified a novel nuclear structure called PML bodies which serve as a storage depot for various regulatory proteins. He is the Chief Science Officer for Rockland Immunochemicals and has more than 30 years of academic and industrial expertise in virology, immunology, host-agent interaction, autoimmune diseases, cancer biology, antibody production and engineering, protein purification and recombinant technology.

http://www.rockland-inc.com/chief-science-officer.aspx

ascoli@rockland-inc.com